Cite
HARVARD Citation
Zhang, X. et al. (2022). Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. Journal for immunotherapy of cancer. 10 (3), p. . [Online].